{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"68","value":"275"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"description":"Presented with descriptive statistics.","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive xisomab 3G3 IV or via catheter within 48 hours of catheter placement. Patients then receive standard of care chemotherapy 2 days later. After approximately 2 weeks, patients undergo standard of care ultrasound for possible CAT.\n\nXisomab 3G3: Given IV or via catheter","id":"OG000","title":"Supportive Care (Xisomab 3G3)"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Up to end of treatment visit (day 18)","title":"Quantification of Coagulation Measures: Platelet Count","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"cells*K/mm^3"}